CN1434682A - Dietary supplement system - Google Patents
Dietary supplement system Download PDFInfo
- Publication number
- CN1434682A CN1434682A CN00818960A CN00818960A CN1434682A CN 1434682 A CN1434682 A CN 1434682A CN 00818960 A CN00818960 A CN 00818960A CN 00818960 A CN00818960 A CN 00818960A CN 1434682 A CN1434682 A CN 1434682A
- Authority
- CN
- China
- Prior art keywords
- prescription
- secondary bag
- bag
- vitamin
- dietary supplement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 23
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 59
- 239000011707 mineral Substances 0.000 claims abstract description 59
- 229940088594 vitamin Drugs 0.000 claims abstract description 52
- 229930003231 vitamin Natural products 0.000 claims abstract description 52
- 235000013343 vitamin Nutrition 0.000 claims abstract description 52
- 239000011782 vitamin Substances 0.000 claims abstract description 52
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 45
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 238000009472 formulation Methods 0.000 claims abstract description 25
- 235000010755 mineral Nutrition 0.000 claims description 57
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 21
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 15
- 229910052791 calcium Inorganic materials 0.000 claims description 15
- 239000011575 calcium Substances 0.000 claims description 15
- 229910052742 iron Inorganic materials 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 239000012190 activator Substances 0.000 claims description 8
- 235000015097 nutrients Nutrition 0.000 claims description 8
- 239000011701 zinc Substances 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- 125000001931 aliphatic group Chemical group 0.000 claims description 7
- 230000008485 antagonism Effects 0.000 claims description 7
- 230000036541 health Effects 0.000 claims description 7
- 239000010941 cobalt Substances 0.000 claims description 6
- 229910017052 cobalt Inorganic materials 0.000 claims description 6
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 6
- 241000124008 Mammalia Species 0.000 claims 7
- 239000005557 antagonist Substances 0.000 abstract description 15
- 239000013589 supplement Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 30
- 239000000123 paper Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 15
- 230000033001 locomotion Effects 0.000 description 12
- 239000002775 capsule Substances 0.000 description 11
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 10
- -1 aluminium Iodine Copper Iron Molybdenum Chemical compound 0.000 description 10
- 239000003963 antioxidant agent Substances 0.000 description 10
- 230000003078 antioxidant effect Effects 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 10
- 102000040350 B family Human genes 0.000 description 9
- 108091072128 B family Proteins 0.000 description 9
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 9
- 235000021355 Stearic acid Nutrition 0.000 description 9
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 9
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 9
- 239000011669 selenium Substances 0.000 description 9
- 229910052711 selenium Inorganic materials 0.000 description 9
- 239000008117 stearic acid Substances 0.000 description 9
- 239000011573 trace mineral Substances 0.000 description 9
- 235000013619 trace mineral Nutrition 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 8
- 230000003042 antagnostic effect Effects 0.000 description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 8
- 239000008108 microcrystalline cellulose Substances 0.000 description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000000890 drug combination Substances 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- 229910052802 copper Inorganic materials 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 4
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 4
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 4
- 229960000367 inositol Drugs 0.000 description 4
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 4
- 229910052750 molybdenum Inorganic materials 0.000 description 4
- 239000011733 molybdenum Substances 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 4
- 229910052710 silicon Inorganic materials 0.000 description 4
- 239000010703 silicon Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 238000009739 binding Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- 229910052804 chromium Inorganic materials 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 3
- 229940124530 sulfonamide Drugs 0.000 description 3
- 229910052720 vanadium Inorganic materials 0.000 description 3
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229960004308 acetylcysteine Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000037058 blood plasma level Effects 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229940100486 rice starch Drugs 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- ZYTKAJZTLXIXOE-RELJEZBFSA-N (2r)-2-acetamido-3-sulfanylpropanoic acid;(2s)-2-amino-5-[[(2r)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC(=O)N[C@@H](CS)C(O)=O.OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O ZYTKAJZTLXIXOE-RELJEZBFSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- AWEKTCPRYZTNFJ-UHFFFAOYSA-N [Ca].[Cu].[Mn] Chemical compound [Ca].[Cu].[Mn] AWEKTCPRYZTNFJ-UHFFFAOYSA-N 0.000 description 1
- RMTFBWYCPIVRAR-UFLZEWODSA-N [Mg].OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12 Chemical compound [Mg].OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12 RMTFBWYCPIVRAR-UFLZEWODSA-N 0.000 description 1
- WVYIHYKZZHEJTC-UHFFFAOYSA-N [P].[Zn].[Fe] Chemical compound [P].[Zn].[Fe] WVYIHYKZZHEJTC-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- BLJNPOIVYYWHMA-UHFFFAOYSA-N alumane;cobalt Chemical compound [AlH3].[Co] BLJNPOIVYYWHMA-UHFFFAOYSA-N 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 108010042362 beta-Lipotropin Proteins 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 229940046074 boron 1.5 mg Drugs 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 description 1
- 230000025938 carbohydrate utilization Effects 0.000 description 1
- 239000011111 cardboard Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000002508 compound effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000002079 cooperative effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- WJZHMLNIAZSFDO-UHFFFAOYSA-N manganese zinc Chemical compound [Mn].[Zn] WJZHMLNIAZSFDO-UHFFFAOYSA-N 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000011087 paperboard Substances 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 150000003254 radicals Chemical group 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
Abstract
A dietary supplement system is described having three variant vitamin and mineral formulations wherein each formulation contains no known antagonists. The system utilizes a supplement package (1) that consists of three sub-packs that each house one of the three variant vitamin and mineral formulations. The sub-packs are detachably connected to one another and are removably attached to a flip-card.
Description
Invention field
The method that the present invention relates to the nutrient field and carry out these nutrients.More particularly, it relates to different vitamin and mineral formulations and uses the method for these different formulations by multiple dose administration.
Background of invention
As everyone knows, human body need balancedly be taken in essential vitamin, mineral matter, trace element and antioxidant.Have only 1% people to take in balanced diet among the known American.Thereby, do not obtain an amount of in most of people's the diet consumption to healthy and happy essential various vitamins, mineral matter and trace element.And unbalanced vitamin in the diet, mineral matter, trace element and antioxidant can cause a large amount of health problems.
People just know that vitamin and mineral matter can produce stirring effect and antagonistic effect mutually in field of nutrition for a long time.For example, when with vitamin C, when excessive B9 (folic acid) or potassium were taken together, cobalamin can be destroyed.On the other hand, when with vitamin D, E, selenium and aliphatic acid (as Omega-3 and Omega-6) be when taking together, the uptake of vitamin A increases.
Although there is antagonistic effect in the nutrient, a kind of system that can avoid this effect is not also invented by nutrition educational circles.But the Multivitamin sheet of taking every day can not provide the dosage of optimal vitamin and mineral matter at present.And, lack excitement and/or antagonist properties that the operable short-cut method of common people utilizes known certain vitamin and mineral matter at present.And in order to design a kind of effective make-up system, the researcher must study for example elimination factor of compound of excitement and/or antagonist properties and other performance.At which vitamin of decision and mineral matter should take together, after which should separately be taken, some different vitamin needses were separately bought.Then, vitamin and mineral matter should separate or unite use with it according to their excitement and antagonist properties.Finally, need one of design to take the table that vitamin and mineral matter make their maximum effect respectively.This process is consuming time, the process of inefficiency.And as if because the user has to take a large amount of different tablets, this system can produce relatively poor compatibility.
Summary of the invention
The invention provides a kind of vitamin that utilizes, mineral matter, trace element and the excitement of antioxidant and the system of antagonist properties.More particularly be exactly that it provides multiple different vitamin and mineral formulations and the method for using these prescriptions.The prescription that has 2 kinds of different vitamins and mineral matter at least was one day different time administration.These different prescriptions do not contain known antagonistic, preferably can contain some activators at least.And these different formulations are on the same day different time administration, and barrier packaging.All barrier packaging prescriptions (dosage) that use on the same day all place a supply bag.This design makes the system of the excitement that utilizes vitamin and mineral matter and antagonist properties easy to use.
Accompanying drawing is described
Fig. 1 is the exterior perspective view that shows the single supply bag of three folding secondary bags of parcel in folding the opened scraps of paper.
Fig. 2 is the stereogram of single supply bag, shows to be attached to three not inside of folding the opened scraps of paper on the not folding secondary bag ridge.
Fig. 3 is the stereogram of single supply bag, shows to be attached to three not outer surfaces of folding the opened scraps of paper on the not folding secondary bag ridge.
Describe in detail
The present invention focuses on the vitamin that will separate, and mineral matter, trace element and antioxidant synthesize the different formulations one day different time administration. These are filled a prescription according to used vitamin, mineral matter, the excitement of trace element and antioxidant and antagonist properties design.
Chemical substance effectiveness in vivo can comprise antagonistic effect with different term descriptions, stirring effect, bioavilability, and clearance rate.Antagonist is defined as reducing the compound of second kind of compound effect.Antagonist is to suppress the biochemistry of another kind of compound and the inhibitor of pharmacologically active.Antagonist also can be to absorb the blocking agent that works by suppressing another kind of compound.At last, antagonist can be competed binding site with another compound.
On the other hand, activator is a kind of sink effect or active compound that can enlarge another kind of compound.Activator can act synergistically with other compound.The collaborative compound can increase the other side's uptake and blood concentration mutually, and perhaps activity level perhaps selectively reduces the other side's chemistry mutually and eliminates.
At last, bioavilability is meant the dose ratio that arrives the circulatory system in the dosage, and clearance rate is meant the elimination ratio of compound at blood plasma or blood middle concentration.
Design the present invention fills a prescription and makes do not have known vitamin and the mineral matter that antagonistic effect is arranged in same prescription, and the combination in same prescription of known activator.Take this class prescription and will improve vitamin, mineral matter, trace element and antioxidant bioavailability.In some embodiments, contained synergistic vitamin, mineral matter, trace element, antioxidant and/or essential amino acid in these prescriptions.In addition, partially or completely constitute in the composition of some embodiments by herbaceous plant.The composition that vitamin that table 1 demonstration is different and mineral formulations are possible and their excitement and antagonist properties.
Table 1
Vitamin/mineral | Activator | Antagonist |
????A | D, E, selenium, aliphatic acid | |
Beta carotene | Aliphatic acid | Dosage surpasses the E of 600iu |
????E | Selenium, A, aliphatic acid | Inorganic iron |
????D | Calcium | |
????K | Aliphatic acid | |
????B1 | B family compound | |
????B2 | B family compound | |
????B3 | B family compound | |
????B5 | B family compound | |
????B6 | B family compound | |
????B9 | B family compound | Excessive B12 |
????B12 | B family compound (low dosage B9) | Potassium, excessive B9 and C |
????C | Iron, calcium, bioflavonoid | Excess copper and B12, sulfanilamide (SN), selenium |
Biotin | ||
Magnesium | ???D | A, E, K, excessive calcium, phosphate |
Iron | C, calcium | Phosphorus, E, zinc, Excessive Manganese |
Zinc | ???A | Molybdenum, calcium, copper, iron |
Phosphorus | Zinc, iron, aluminium | |
Iodine |
Copper | Iron | Molybdenum, zinc, excessive C |
Calcium | D, boron, magnesium | A, phosphorus |
Molybdenum | Sulfanilamide (SN), copper | |
Manganese | Calcium, magnesium (heavy dose) iron, phosphate | |
Potassium | ????B12 | |
Selenium | ????E | ????C |
Chromium | Vanadium | |
Vanadium | Chromium | |
Boron | ||
Fluorine | Calcium, aluminium | |
Cobalt | B12 (catalyst) | |
Bioflavonoid | ????C | |
????Omega-3 | ????A,E,K | |
????Omega-6 | ????A,E,K | |
Acetylcysteine | ||
Glutathione | ||
Inositol | ||
Choline | ||
Hydroxyapatite | ||
Silicon | ||
Co-Q10 |
Each compound that table 1 is listed is applied to human body with proper dosage, to healthy useful.For example, bioflavonoid and vitamin C synergy can be protected capillary structure.Copper is essential to neurological health.Potassium is regulated the transportation of iuntercellular nutrition.Selenium is that the protection immune system prevents the important antioxidant that free radical forms.Cobalamin is to keep the healthy key factor of nervous system (comprising brain cell).Phosphorus is to the bone growth of health, and tooth develops, and renal function and nerve impulse conduction are essential.Vitamin C is very important to formation of all cells collagen and connective tissue.Vitamin E is an antioxidant, can prevent many substance decomposition in oxidation reaction too early in the body and the body.PABA helps health protein, fat and carbohydrate utilization, and it formation is essential to haemocyte (especially red blood cell), and its correct skin pigment and skin health are also very important.Calcium helps strong bone and tooth, and is especially extremely important to teenager and young married woman, because it can reduce day danger of future trouble osteoporosis.
Use different prescriptions can make the wholesome effect maximization of these compounds.Do not contain any known antagonist (as limiting in the table 1) in the prescription of these vitamins and mineral matter.And the prescription with mutual antagonism should be taken at different time on the same day.The administration of these prescriptions preferably at least at interval 1 hour, 4 hours at most at interval.Because the time that the decomposition of permission compound and blood plasma absorb is abundant, by separately taking mutual antagonist compound, these vitamins and mineral matter can be kept the PC high level more previously obtd than other make-up system in blood plasma.Keep vitamin, mineral matter, trace element and the higher PC of antioxidant will more be good for one's health.
Produce antagonistic effect when using though some compound high dose is united, these compounds are united when using at low dosage may produce stirring effect.Therefore, present invention resides in the identical prescription low dosage unites and uses these compounds.For example, produce antagonistic effect when Cobastab 9 and B12 high dose are taken, but low dosage produces cooperative effect when taking.Similarly, produce antagonistic effect when cobalamin and C high dose use, but low dosage there is not this effect when using.Therefore, considered this low dosage drug combination in certain embodiment of the present invention.
Some drug combination of compound is considered to useful especially to health.For example, vitamin C, iron and calcium is drug combination in same prescription, to healthy useful especially.Similarly, it is better that liposoluble vitamin, vitamin K for example, E and A and aliphatic acid such as Omega-3 and Omega-6 are united when taking their absorption.The B family vitamin absorbs better (but the dosage of this drug combination B9 and B12 should be relative low) with composite form.At last and vitamin A when taking together, zinc absorbs better.Similarly and cobalt take together, it is better that B12 absorbs.Since these special drug combinations are considered to healthy useful especially, the present invention has also considered the drug combination (limiting as table 1) of many other activators.
Some compound is taken at one day special time can produce extra health effect.Can increase sleep REM and impel loosening all muscles when for example, the prescription that contains 2 kinds or above mineral matter is taken at night.The prescription that contains B family vitamin compound is taken in the morning and can be made the people energetic.Similarly, B12 takes at noon and can impel the people energetic afternoon, continues one day human thinking agility.
Prescription of the present invention is best effectively to be utilized according to life style and/or sex.Just the target group of these prescriptions is with sex and/or whether crowd's individuality lacks exercise, gentleness, and spiritual high-pressure or advanced age are the basis.For example, the make-up water of required iron of the women in 20-25 year that lacks exercise and B12 gentle one actively the climacteric women of motion be different.
Prescription of the present invention also can fixedly be used in the crowd of certain income level.Just, these prescriptions comprise the minimum supply level of accepting at certain target group, best supply level, or supply level placed in the middle.Provide the product characteristics of minimum acceptable level to be that price is relatively low.Therefore, different formulations of the present invention can special design to satisfy wide target group's different demands, comprise motion, age, the difference of sex and income level.Table 2 has shown the optimal dosage scope of different crowd.
In some embodiments, the present invention considers pregnancy, advanced age, few motion, the woman's of modest movement or nervous and high degree of motion or stress optimal dose and advanced age, few motion, the man's of modest movement or mental excitation and high degree of motion or stress optimal dose.The target group of few motion comprise the people of office work or the people of the minimum active operation of other needs.Selectable, because the level of each compound that contains at the prescription of the colony of few motion life style is lower, the cost of these prescriptions is low, and product can be sold those people that can not the supply of Zhi Fuqi high level with lower price.On the other hand, modest movement or nervous colony comprise many students, sales force's kimonos author that works, amateur etc.At last, high degree of motion or nervous colony comprise many administrative personnels, builder, professional athlete etc.The dosage definition high dose that table 2 provides is " H ", and median dose is that " M " and low dosage are " L ".Concerning a kind of specific compound, high dose is corresponding to given dose scope 1/3 high dose place, and median dose is corresponding to about 1/3 median dose place of given dose scope, and low dosage is corresponding to about 1/3 low dosage place of given dose scope.
Table 2
Vitamin | Scope | Conceived women | Small number of activity women | The moderate activity women | High activity women | Older women | The small number of activity male sex | The moderate activity male sex | The high activity male sex | The older male sex |
??A | ??10000-25000iu | ??M | ??L | ??M | ??H | ??H | ??L | ??M | ??H | ??H |
??B1 | ??10-100mg | ??* | ??L | ??M | ??H | ??H | ??L | ??M | ??H | ??H |
??B2 | ??15-100mg | ??* | ??M | ??H | ??H | ??H | ??L | ??M | ??H | ??H |
??B3 | ??25-100mg | ??* | ??L | ??M | ??H | ??H | ??L | ??M | ??H | ??H |
??B5 | ??20-100mg | ??* | ??L | ??M | ??H | ??H | ??L | ??M | ??H | ??H |
??B6 | ??20-100mg | ??* | ??M | ??H | ??H | ??H | ??L | ??M | ??H | ??H |
??B9 | ??200-800mcg | ??M | ??L | ??M | ??H | ??H | ??M | ??M | ??H | ??H |
??B12 | ??100-1000mcg | ??* | ??L | ??M | ??H | ??M | ??L | ??M | ??H | ??H |
??C | ??250-1200mg | ??M | ??L | ??M | ??H | ??H | ??L | ??M | ??H | ??H |
??D | ??200-400iu | ??* | ??L | ??M | ??H | ??H | ??L | ??M | ??H | ??H |
??E | ??50-100iu | ??* | ??L | ??M | ??H | ??H | ??L | ??M | ??H | ??H |
??K | ??30-80mcg | ??* | ??L | ??L | ??M | ??M | ??L | ??L | ??M | ??M |
Calcium | ??1000-1500mg | ??* | ??M | ??H | ??H | ??H | ??L | ??M | ??H | ??H |
Chromium | ??100-300mcg | ??* | ??L | ??L | ??M | ??M | ??L | ??L | ??M | ??M |
Cobalt | ??50-20mg | ??* | ??L | ??M | ??H | ??M | ??L | ??M | ??H | ??M |
Copper | ??2-3mg | ??* | ??L | ??M | ??H | ??M | ??L | ??M | ??H | ??H |
Iron | ??10-20mg | ??* | ??M | ??M | ??H | ??H | ??L | ??L | ??M | ??H |
Magnesium | 400-500mg | * | ?L | ?L | ?M | ?M | ?L | ?L | ?M | ?M |
Manganese | 1-2mg | * | ?L | ?L | ?M | ?M | ?L | ?L | ?M | ?M |
Molybdenum | 75-250mcg | * | ?L | ?L | ?M | ?M | ?L | ?L | ?M | ?M |
Potassium | 50-200mg | * | ?L | ?L | ?M | ?M | ?L | ?M | ?H | ?H |
Selenium | 7-200mcg | * | ?L | ?M | ?H | ?H | ?L | ?M | ?H | ?H |
Vanadium | 15-30mcg | * | ?L | ?L | ?L | ?L | ?L | ?L | ?M | ?L |
Zinc | 15-30mg | * | ?L | ?M | ?M | ?M | ?M | ?H | ?H | ?H |
Omega-3 | 150-500mg | * | ?L | ?L | ?M | ?L | ?L | ?L | ?M | ?L |
Omega-6 | 200-800mg | * | ?L | ?L | ?M | ?M | ?L | ?L | ?M | ?M |
NAC | 50-300mg | * | ?L | ?M | ?H | ?H | ?L | ?M | ?H | ?H |
Glutathione | 50-800mcg | * | ?L | ?L | ?M | ?M | ?L | ?L | ?M | ?M |
Inositol | 10-50mg | * | ?L | ?L | ?H | ?M | ?L | ?L | ?H | ?M |
Bioflavonoid | 50-500mg | * | ?L | ?L | ?M | ?M | ?L | ?L | ?M | ?M |
Choline | 50-400mg | * | ?L | ?L | ?M | ?M | ?L | ?L | ?M | ?M |
Fluorine | 50-800mg | * | ?L | ?L | ?M | ?M | ?L | ?L | ?M | ?M |
Boron | 0.3-3.0mg | * | ?L | ?L | ?M | ?M | ?L | ?L | ?M | ?M |
Phosphorus | 100-400mg | * | ?L | ?L | ?M | ?L | ?L | ?L | ?M | ?L |
Iodine | 150-250mcg | * | ?L | ?L | ?L | ?L | ?L | ?L | ?L | ?L |
Coenzyme-Q10 | 5-30mg | * | ?L | ?L | ?M | ?M | ?L | ?L | ?H | ?M |
Silicon | 20-100mcg | * | ?L | ?L | ?L | ?L | ?L | ?L | ?L | ?L |
Biotin | 100-500mcg | * | ?L | ?L | ?M | ?M | ?L | ?L | ?M | ?M |
Vitamin and mineral formulations be by the capsule and pill of standard, capsule, and tablet, sportsbars or solution (tablet has fast disintegration rate) form administration, and these medicines all are contained in a kind of single packaging system.Can be selectively, these prescriptions can be with the colloidal form administration, directly colloid is extruded in user's the mouth to take from packing (ampere or gel bag).
As can be seen from Figure 1, the packaging system of this uniqueness comprises an independent supply bag 1, and it contains a plurality of secondary bags 3.In a plurality of secondary bags 3 the different vitamins and the mineral formulations of taking is housed in one day.The vitamin of each doses and mineral formulations are placed in the secondary bag.
In the most preferred embodiment, a plurality of secondary bags are designed to folding silver foil bag.Secondary bag 3 is selectively used plastics, paper, and cardboard or the like is made.Can print additional literal or pattern on the secondary bag 3 can discern the user will to take any special formulation.In addition, secondary bag 3 preferably links mutually separably, and each secondary bag 3 seals fully with other secondary bag like this.Secondary bag 3 edges seal with standard method, comprise folding, heat-sealing or bonding.Secondary bag 3 can directly be attached to and can open on the scraps of paper 5, or is attached to indirectly and can opens on the scraps of paper 5 by being attached to other secondary bag 3.Secondary bag 3 also can be attached to respectively to open and make secondary bag 3 no longer interlink on the scraps of paper 5.
Can open that the scraps of paper 5 and secondary bag 3 are common to constitute a single supply bag 1, be equipped with in the supply bag 1 can be in one day the drug dose of multiple dosing.The optimal material that can open the scraps of paper 5 is a heavy paper, selectively also can be with hardboard, and plastics or other analog material replace.Can open ridge 9 of the scraps of paper 5 preferred moulding one-tenth.The width of ridge 9 is approximately 5/8 inch as shown in Figure 1.Ridge 9 selectively also can have other different width, but its size preferably can be held all secondary bags 3 structure after overlapping.Such width is usually between 1/16 to 1 inch.
Preferably can open punching formation removable part 7 on the scraps of paper 5.Print additional written material 10 on the removable part 7, when written material after can open the scraps of paper 5 and separate, just can use as show-card.Written material 10 comprises the and products retail distributed intelligence, as its telephone number, and homepage and e-mail address, and/or geographical position.Written material 10 also comprises order information, and advertisement is perhaps about the information of product.Removable part 7 preferred sizes are sizes that the standard show-card is arranged.Be specifically, removable part 7 preferred lengths are about 3.5 inches, widely are about 2 inches.Selectively, removable part 7 can be the shape and the size, particularly length of any configuration between the 2-8 inch, width is at the 1-6 inch.
In the most preferred embodiment, a single supply bag 1 has the secondary bag of 3 separation.According to Fig. 2, the secondary bag of these 3 separation further comprises secondary bag 11 in morning, and secondary bag 15 of secondary bag 13 of noon and night, each secondary bag is equipped with morning vitamin that noon and evening take and mineral formulations respectively.Morning secondary bag 11 with noon secondary bag 13 as noon secondary bag 13 the same with secondary bag 15 of night be separable binding.Each secondary bag prints additional literal or figure makes it to distinguish with other secondary bag.Particularly, the sun of secondary bag 11 figures that print additional in morning as rising, or literal is as " morning ", when " a.m " or " breakfast time " takes medicine in the bag to help user's decision.Similarly, noon, secondary bag 13 figures that print additional were described the sun at high noon or literal as " high noon ", " noon ", or " lunchtime "; Secondary bag 15 figures that print additional were described one and were taken turns the moon or literal as " dusk ", " at dusk ", " night ", " p.m " or " date for dinner " night.
The secondary bag of these 3 bindings is fixed on the inner surface 19 that can open the scraps of paper 5 by following closely 17.As shown in the figure, connect be preferably placed at noon secondary bag 13 and night secondary bag 15 between.This connection can prevent noon secondary bag 13 and night secondary bag 15 from opening the premature disengagement on the scraps of paper.These secondary bags also selectively are fixed in and can open on the scraps of paper with the method for attaching of adhesive tape or other standard.
In a kind of preferred configuration, morning secondary bag 11 with noon secondary bag 13 junction folding, make morning secondary bag 11 be positioned at secondary bag 13 at noon above.Similarly, night secondary bag 15 with noon secondary bag 13 junction folding, night secondary bag is positioned on the secondary bag 11 in folding morning.By guaranteeing the firm of this structure towards the inner surface 19 folding scraps of paper 5 that can open that can open the scraps of paper 5 at ridge 9 places.As shown in Figure 1, this structure makes 3 secondary bags be enclosed in folding the opened scraps of paper 5 inside fully, its size such as same single secondary bag 3.
Describe some embodiment preferred of the present invention in detail by the mode of following examples.
Embodiment 1
As nutrient, the user is water or the vitamin and the mineral formulations that contain in the taking dose 1 when having meal at first.After 1 to 4 hour, the user takes prescription 2, after 1 to 4 hour, takes prescription 3.I.
Prescription 1 (4) Tablet 1:Iron 15mg boron 1.5mg molybdenum 100mcg acetylcysteine 250mg glutathione 500mcg microcrystalline cellulose 10 (sieving) 252mg/unitSol-U-Tab 30.00mg stearic acid 35.00mg dolomol 7.50mgTablet 2:B1 100mgB2 100mgB3 100mg calcium 150mgB6 100mgB9 800mcgB12 100mcgP.A.B.A 50mg microcrystalline cellulose 10 121.24mgSol-U-Tab 30.00mg stearic acid 35.00mg dolomol 8.50mgTablet 3:Calcium 500mg vitamin D 100 MIU/GM 400IUSol-U-Tab 42mg stearic acid 55.00mg dolomol 15.00mg
Tablet 4:C 1200mg bioflavonoid particle 300mg microcrystalline cellulose 10 200.00mgSol-U-Tab 43.00mg stearic acid 55.00mg dolomol 14.40mgII.
Prescription 2 (4) Tablet 1:B12 800mcg biotin 300mcg choline 200mg inositol particle 50mg stearic acid 30.00mg microcrystalline cellulose 10 152.47mg magnesium 5.50mgSol-U-Tab 25mgTablet 2 (capsule and pill):E 400iuA 25.000iu
Tablet 3 (capsule and pill):Omega-3 300mgOmega-6 500mg
Tablet 4:Chromium 200mcg selenium 100mcg vitamin K1 %trit 50mcg cobalt 200mcg manganese 10mg hydroxyapatite 50mg zinc 30mg microcrystalline cellulose 10 152.47mg stearic acid 30.00mg dolomol 5.50mgSol-U-Tab 25mgIII.Prescription 3 (2 tablets of tablets, 1 capsules) Tablet 1 and 2:Dicalcium Phosphate
Calcium 250mg
Phosphorus 220mg potassium 189mg iodine 100mcg fluorine 400mcg copper 2mg vanadium 40mg silicon 20mg magnesium 500mg amides compound (maltodextrin) 150.00mg dolomol 20.00mgSol-U-Tab 50.00mgTablet 3 (capsule):Co-Q10 20mg white rice starch 100.00mg amides compound 150.00mg dolomol 20.00mg
By taking the dosage of 3 parts of unique formula in one day, the blood concentration of these compounds is improved and remains on a high blood plasma level of blood concentration that uses other complement agent than before and reached.And, by separately taking 3 parts of nutrient agent, can avoid higher medicine clearance rate.
Embodiment 2
As nutrient, the user takes vitamin and the mineral formulations that is contained in the bag in morning morning, takes the medicine in the bag at noon noon, takes the medicine in the bag in night evening, takes by water or dining.
I. morning bag
Tablet 1:
Iron ... 15mg
Boron ... 1.5mg
Tablet 2:
B1…………………………………………………………100mg
B2…………………………………………………………100mg
B3…………………………………………………………100mg
B5…………………………………………………………150mg
B6…………………………………………………………100mg
B9…………………………………………………………800mg
B12…………………………………………………………100mg
PABA………………………………………………………50mg
Molybdenum ... 100mcg
Tablet 3:
Acetylcysteine (NAC) ... 250mg
Glutathione ... 500mcg
Calcium ... 750mg
D…………………………………………………………………400i.u.
Tablet 4:
C…………………………………………………………………1200mg
Bioflavonoid ... 300mg
Other composition among the tablet 1-4:
Dolomol, stearic acid, Sol-U-Tab, microcrystalline cellulose 10
II. high noon
Tablet 1:B12 ... the 800mg biotin ... the 300mcg lipotropin ... the 200mg inositol ... 50mg
Tablet 2:Chromium ... 200mcg zinc ... 30mgK ... the 50mcg cobalt ... the 200mcg hydroxyapatite ... 50mg manganese ... 10mg selenium ... 100mgCapsule 1:E ... 400i.u.A ... 25000i.u.
Capsule 2:Omega-3 ... 500mgOmega-6 ... 400mg
Other composition among tablet 1-2 and the capsule 1-2:Dolomol, stearic acid, Sol-U-Tab, microcrystalline cellulose 10
III. night
Tablet 1 and 2:Copper ... the 2mg vanadium ... the 40mcg Dicalcium Phosphate
Calcium ... 250mg
Phosphorus ... 220mg potassium ... the 189mg fluorine ... 400mcg iodine ... 100mcg silicon ... 20mcg magnesium ... 500mgCapsule 1:Co-Q10 ... 20mg
Other composition in tablet 1-2 and the capsule 1:
Dolomol, stearic acid, Sol-U-Tab, microcrystalline cellulose 10, white rice starch, and amides compound
By taking the dosage of 3 parts of unique formula in one day, the blood concentration of these compounds is improved and remains on a high blood plasma level of blood concentration that uses other complement agent than before and reached.And, by separately taking 3 parts of nutrient agent, can avoid higher medicine clearance rate.
Claims (33)
1. dietary supplement system, described dietary supplement system comprises:
First kind of vitamin and mineral formulations, wherein said first kind of prescription comprises multivitamin and/or mineral matter, do not have vitamin and/or the mutual antagonism of mineral matter in first kind of prescription.
Second kind of vitamin and mineral formulations, wherein said second kind of prescription comprises multivitamin and/or mineral matter, do not have vitamin and/or the mutual antagonism of mineral matter in second kind of prescription.
Place the supply bag of first kind and second kind prescription, wherein said supply bag comprises first secondary bag and second secondary bag, wherein said first secondary bag can separate from the supply bag, also can separate with second secondary bag, wherein said first is equipped with first kind and second kind of prescription respectively with second secondary bag.
2. dietary supplement system according to claim 1, wherein said supply bag further comprises a kind of scraps of paper that open, the secondary bag of wherein said first and second is removable to be attached to described opening on the scraps of paper.
3. dietary supplement system according to claim 1, the wherein said scraps of paper that open have a removable part.
4. dietary supplement system according to claim 1 adds on the wherein said removable part and is printed on written material.
5. dietary supplement system according to claim 1, further the comprising of wherein said supply bag:
The 3rd secondary bag, wherein the 3rd secondary bag can separate with the supply bag, also can separate with second secondary bag with first; And
The third vitamin and mineral formulations, wherein said the third prescription contains multivitamin and/or mineral matter, does not wherein have vitamin and/or the mutual antagonism of mineral matter in the third prescription, and the third prescription places the 3rd secondary bag.
6. dietary supplement system according to claim 1, wherein said first kind of prescription comprises:
Iron;
Calcium; With
C。
7. dietary supplement system according to claim 1, wherein said first kind of prescription comprises:
B1;
B2;
B3;
B5;
B6;
B9; With
B12。
8. dietary supplement system according to claim 1, wherein said first kind of prescription comprises:
B12; With
Cobalt.
9. dietary supplement system according to claim 1, wherein said second kind of prescription comprise Omega-3 or Omega-6 aliphatic acid and:
A;
E; With
K。
10. dietary supplement system according to claim 1, wherein said second kind of prescription comprises:
Zinc; With
A。
11. dietary supplement system according to claim 5, wherein said the third prescription comprises 2 kinds or several mineral materials.
12. dietary supplement system according to claim 1, wherein said first secondary bag is connected separably with second secondary bag.
13. dietary supplement system according to claim 5, wherein said first secondary bag is connected separably with second secondary bag, and wherein said second secondary bag is connected separably with the 3rd secondary bag.
14. dietary supplement system according to claim 2, wherein said supply bag further comprises the 3rd the secondary bag that contains the third vitamin and mineral formulations, and wherein said the 3rd secondary bag is connected separably with first or second secondary bag.
15. dietary supplement system according to claim 1, wherein in described first kind or second kind of prescription, having 2 kinds of vitamins and/or mineral matter at least is activator.
16. keeping and improving purposes in the mammiferous general health situation according to any described dietary supplement system in the aforementioned claim.
17. be used for keeping and improving the purposes of the medicine of mammiferous general health situation in preparation according to any described dietary supplement system among the claim 1-15.
18. the purposes of PC in a higher level according to multivitamin and the mineral matter in keeping the higher mammal body of any described dietary supplement system among the claim 1-15.
19. the purposes of PC in the medicine of a higher level according to multivitamin and the mineral matter in the higher mammal body is kept in preparation of any described dietary supplement system among the claim 1-15.
20. to the method that mammal is taken nutrient, it comprises:
From the supply bag that comprises the secondary bag of first and second, isolate the secondary bag that first comprises first kind of vitamin and mineral formulations;
Open first secondary bag;
From described first secondary bag, take out first kind of prescription, and take first kind of prescription to mammal;
Wait for one section special time;
From described supply bag, isolate described second the secondary bag that contains second kind of vitamin and mineral formulations;
Open second secondary bag, and
From second secondary bag, take out second kind of prescription, and take second kind of prescription to mammal.
21. method according to claim 20, wherein said first kind of prescription comprises multivitamin and/or mineral matter, wherein do not have vitamin and the mutual antagonism of mineral matter in first kind of prescription; Wherein second kind of prescription comprises multivitamin and/or mineral matter, wherein do not have vitamin and the mutual antagonism of mineral matter in second kind of prescription.
22. method according to claim 20, wherein said supply bag further comprises a kind of scraps of paper that open, and wherein said first is attached to this opening on the scraps of paper with second secondary bag in the mode that can separate.
23. method according to claim 20, wherein said first secondary bag is connected with described second secondary bag separably, further comprises first secondary bag is separated with second secondary bag.
24. method according to claim 20, wherein said supply bag comprise the 3rd secondary bag, it further comprises:
Take the back for described mammal second kind of prescription and wait for one section special time;
The 3rd the secondary bag that the third vitamin and mineral formulations are housed separated from the supply bag;
Open the 3rd secondary bag;
Take out the third prescription and take the third prescription for described mammal.
25. method according to claim 24, wherein said the third vitamin and mineral formulations comprise multivitamin and/or mineral matter, wherein do not have vitamin and/or the mutual antagonism of mineral matter in described the third prescription, wherein the third prescription is contained in described the 3rd the secondary bag.
26. the described method of claim 24, wherein said the 3rd secondary bag is connected separably with first or second secondary bag, and it further comprises separates described the 3rd secondary bag with first or second secondary bag.
27. method according to claim 21, wherein at least two kinds of described multivitamins and/or mineral matter are activators in described first kind or second kind of prescription.
28. method according to claim 21, wherein said first kind of prescription comprises:
Iron;
Calcium; With
C。
29. method according to claim 21, wherein said first kind of prescription comprises:
B1;
B2;
B3;
B5;
B6;
B9; With
B12。
30. method according to claim 25, wherein said first kind of prescription comprises:
B12; With
Cobalt.
31. according to the described method of claim 21, wherein said second kind of prescription comprises: Omega-3 or Omega-6 aliphatic acid and:
A;
E; With
K。
32. according to the described method of claim 21, wherein said second kind of prescription comprises:
Zinc; With
A。
33. method according to claim 25, wherein said the third prescription comprises 2 kinds or several mineral materials.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46063299A | 1999-12-14 | 1999-12-14 | |
US09/460,632 | 1999-12-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1434682A true CN1434682A (en) | 2003-08-06 |
Family
ID=23829472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN00818960A Pending CN1434682A (en) | 1999-12-14 | 2000-12-14 | Dietary supplement system |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1434682A (en) |
AU (1) | AU2431801A (en) |
WO (1) | WO2001043571A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2195269C2 (en) * | 2001-02-14 | 2002-12-27 | Общество с ограниченной ответственностью "МДТ" | Vitamin-mineral complex |
NL1017707C2 (en) * | 2001-03-27 | 2002-10-01 | Jaap Meijer | Vitamin preparation. |
WO2011061687A2 (en) | 2009-11-18 | 2011-05-26 | University Of The Free State | Multiple-phase dietary supplement product |
US20120040018A1 (en) * | 2010-08-10 | 2012-02-16 | Sure-Shot Medical Device Inc. | Ingestible Supplement for Women |
BE1021010B1 (en) * | 2013-03-29 | 2014-12-17 | Omega Pharma Innovation & Development Nv | KIT WITH MULTIPLE FOOD SUPPLEMENTS AND A METHOD OF COMPOSING THEM. |
CA2953286C (en) * | 2014-08-08 | 2023-05-02 | Nestec S.A. | Vitamin b2 for gestational diabetes |
US11083738B2 (en) | 2017-09-28 | 2021-08-10 | Natals, Inc. | Dietary nutrient compositions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4420159A1 (en) * | 1994-06-09 | 1995-12-14 | Helge B Cohausz | Tablet container with compartments |
US5962030A (en) * | 1997-03-07 | 1999-10-05 | Akesis Pharmaceuticals, Inc. | Dietary supplement and method of treatment for diabetic control |
US5922704A (en) * | 1997-12-24 | 1999-07-13 | Feeling Fine Company Llc | Optimal nutritional supplement for men |
-
2000
- 2000-12-14 CN CN00818960A patent/CN1434682A/en active Pending
- 2000-12-14 AU AU24318/01A patent/AU2431801A/en not_active Abandoned
- 2000-12-14 WO PCT/US2000/033946 patent/WO2001043571A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2431801A (en) | 2001-06-25 |
WO2001043571A1 (en) | 2001-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1117571C (en) | Improved calcium dietary supplement | |
Roe | Diet and drug interactions | |
CN102325468B (en) | It is the nutritious supplementary pharmaceutical of more than 50 years old individual raising vigor, immunity, eye and bone health | |
JP2007533607A (en) | Micronutrient supplements | |
CN108991532A (en) | A kind of oral skin-beautifying agent of the collagen peptide comprising separate sources | |
CN1434682A (en) | Dietary supplement system | |
JP2015007092A (en) | Multivitamin/mineral formulation to combat effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without negative side effects of mega dose nutritional supplement | |
CN102150838A (en) | Weight losing composition, preparation containing same and preparation method thereof | |
CN1774179A (en) | Multi-vitamin and mineral supplement for pregnant women | |
RU2410085C2 (en) | Oral composition with controlled release biologically active substances | |
CN1835870B (en) | Micronutrient supplement dispensing package which is safe to children | |
US20090136592A1 (en) | Vitamin preparation | |
CN102578572A (en) | Mineral and vitamin nutritional supplement | |
EP0432700A2 (en) | Use of lithium compounds for the treatment of combination skin | |
US20160271103A1 (en) | Dietary supplement containing alkaline electrolyte buffers | |
Donaldson | Impacts and Interrelationships Between Medications, Nutrition, Dietary Supplements, and Oral Health | |
Messonnier | Nutritional Supplements for the Veterinary Practice: A Pocket Guide | |
Smith | Iron supplementation | |
Smith | Iron supplementation: clinical | |
Taylor | OTC Weight-Loss Products | |
Generic et al. | L-METHYL-MC-NAC (LEVOMEFOLATE CALCIUM, METHYLCOBALAMIN, AND ACETYLCYSTEINE) TABLET, COATED [AVKARE, INC.] |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |